Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 27;14(5):463.
doi: 10.3390/jpm14050463.

HER2 Overexpression in Periampullary Tumors According to Anatomical and Histological Classification-A Systematic Review

Ioan Cătălin Bodea  1   2 , Andra Ciocan  1   2 , Florin Vasile Zaharie  1   2 , Raluca Bodea  2 , Florin Graur  1   2 , Ștefan Ursu  1   2 , Răzvan Alexandru Ciocan  3 , Nadim Al Hajjar  1   2
Affiliations
Review

HER2 Overexpression in Periampullary Tumors According to Anatomical and Histological Classification-A Systematic Review

Ioan Cătălin Bodea et al. J Pers Med. .

Abstract

Pancreatic cancer is one of the most aggressive, heterogeneous, and fatal types of human cancer; therefore, more effective therapeutic drugs are urgently needed. Human epidermal growth factor receptor 2 (HER2) overexpression and amplification have been identified as a cornerstone in this pathology. The aim of this review is to identify HER2 membrane overexpression in relation to pancreatic cancer pathways that can be used in order to develop a targeted therapy. After searching the keywords, 174 articles were found during a time span of 10 years, between 2013 and 2023, but only twelve scientific papers were qualified for this investigation. The new era of biomolecular research found a significant relationship between HER2 overexpression and pancreatic cancer cells in 25-30% of cases. The variables are dependent on tumor-derived cells, with differences in receptor overexpression between PDAC (pancreatic ductal adenocarcinoma), BTC (biliary tract cancer), ampullary carcinoma, and PNETs (pancreatic neuroendocrine tumors). HER2 overexpression is frequently encountered in human pancreatic carcinoma cell lines, and the ERBB family is one of the targets in the near future of therapy, with good results in phase I, II, and III studies evaluating downregulation and tumor downstaging, respectively.

Keywords: HER2; molecular pathway; overexpression; pancreatic cancer; protein receptors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram for the selected studies included in the systematic review identified in three databases, i.e., PubMed, Embase, and Clarivate Web of Science.
See this image and copyright information in PMC

References

    1. Hidalgo M. Pancreatic cancer. N. Engl. J. Med. 2010;362:1605–1617. - PubMed
    1. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J. Clin. 2012;62:10–29. doi: 10.3322/caac.21153. - DOI - PubMed
    1. Lowenfels A.B., Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract. Res. Clin. Gastroenterol. 2006;20:197–209. doi: 10.1016/j.bpg.2005.10.001. - DOI - PubMed
    1. Koorstra J.B., Hustinx S.R., Offerhaus G.J., Maitra A. Pancreatic carcinogenesis. Pancreatology. 2008;8:110–125. doi: 10.1159/000123838. - DOI - PMC - PubMed
    1. Beuran M., Negoi I., Paun S., Ion A.D., Bleotu C., Negoi R.I., Hostiuc S. The epithelial to mesenchymal transition in pancreatic cancer: A systematic review. Pancreatology. 2015;15:217–225. doi: 10.1016/j.pan.2015.02.011. - DOI - PubMed